POZZI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 4.824
EU - Europa 3.200
AS - Asia 1.488
AF - Africa 13
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
Totale 9.548
Nazione #
US - Stati Uniti d'America 4.750
IT - Italia 936
DE - Germania 655
CN - Cina 540
SG - Singapore 511
SE - Svezia 441
IE - Irlanda 349
RU - Federazione Russa 250
GB - Regno Unito 151
HK - Hong Kong 136
VN - Vietnam 119
AT - Austria 99
UA - Ucraina 74
CA - Canada 72
DK - Danimarca 71
IN - India 50
FR - Francia 44
FI - Finlandia 37
KR - Corea 30
JP - Giappone 26
TR - Turchia 25
BE - Belgio 23
ID - Indonesia 20
NL - Olanda 18
MY - Malesia 10
AU - Australia 9
ES - Italia 9
CZ - Repubblica Ceca 8
TW - Taiwan 8
EU - Europa 7
BR - Brasile 6
EG - Egitto 6
HR - Croazia 6
RO - Romania 6
TH - Thailandia 6
CH - Svizzera 5
BG - Bulgaria 4
RS - Serbia 4
SA - Arabia Saudita 3
SC - Seychelles 3
GT - Guatemala 2
LV - Lettonia 2
NG - Nigeria 2
PL - Polonia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 9.548
Città #
Ann Arbor 1.750
Frankfurt am Main 518
Singapore 422
Milan 356
Wilmington 343
Dublin 339
Chandler 329
Dearborn 229
New York 181
Ashburn 160
Woodbridge 152
Hong Kong 136
Princeton 134
Fairfield 130
Houston 125
Nanjing 110
Vienna 99
Santa Clara 98
Seattle 74
Shanghai 72
Jacksonville 71
Guangzhou 63
Boardman 61
Dong Ket 49
Beijing 41
Chicago 30
Nanchang 30
Lawrence 29
Pune 29
Altamura 28
Cambridge 28
Carate Brianza 28
Shenyang 26
Rome 25
Toronto 24
Melzo 23
Helsinki 22
Falls Church 21
Shangdi 21
Jakarta 20
Ottawa 20
Los Angeles 18
Brussels 17
Hangzhou 17
Andover 16
Mainz 16
Sacramento 16
Kunming 15
Tokyo 15
Codroipo 14
Edmonton 14
Florence 14
Yuseong-gu 14
Dallas 13
Jinan 13
Lissone 13
Tianjin 13
San Diego 12
Zhengzhou 12
Fremont 11
Jiaxing 11
Norwalk 11
Romola 10
Sesto San Giovanni 10
Changsha 9
Hyderabad 9
Kiev 9
London 9
Piemonte 9
Washington 9
Bologna 8
Lappeenranta 8
Brno 7
Cagliari 7
Canazei 7
Grafing 7
Hebei 7
Munich 7
Bangkok 6
Genoa 6
Hefei 6
Perugia 6
Taizhou 6
Bergamo 5
Cassano Magnago 5
Council Bluffs 5
Frederick 5
Huizen 5
Induno Olona 5
Lachine 5
Merate 5
Monza 5
Ningbo 5
Novara 5
Paderno Dugnano 5
San Martino in Strada 5
Tanta 5
Trieste 5
Zagreb 5
Catanzaro 4
Totale 6.987
Nome #
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 292
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 286
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 273
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 230
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 212
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 202
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 202
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 199
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 194
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 191
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS 188
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 187
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 181
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 181
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 179
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 177
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 172
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 172
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 165
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 150
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 149
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 148
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 147
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 147
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 147
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 145
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 135
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 133
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 128
Multimodal experimental approach to the study of human neurological diseases 126
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 126
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 125
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 124
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 123
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 122
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 122
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 122
Genetic factors influencing the development of vincristine-induced neurotoxicity 119
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 118
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 116
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 114
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 112
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 109
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 100
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 99
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 98
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 96
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 94
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 93
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 93
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 93
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 92
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 92
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 90
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 90
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 90
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 88
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 88
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 87
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 86
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 85
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 84
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 82
null 80
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 74
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 73
Can different Mice Strains be differently susceptible to Oxaliplatin-Induced Peripheral Neuropathy? 72
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 71
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN) 70
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 67
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity 66
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 63
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 60
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 57
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 54
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 53
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 50
Oxaliplatin neurotoxicity: morpho-functional approach 50
REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI 50
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 47
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 47
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity 46
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 45
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY 42
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 39
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 38
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 34
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 33
High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models 32
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 31
CIPN and its mechanism of development 29
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 29
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 29
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 26
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 23
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 13
Totale 10.403
Categoria #
all - tutte 36.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.051 0 0 0 74 121 204 199 92 95 143 102 21
2020/20212.017 47 63 231 207 156 223 220 236 157 103 140 234
2021/20221.106 111 133 110 97 93 104 49 49 44 52 79 185
2022/20231.884 187 371 239 174 166 306 63 75 136 41 82 44
2023/20241.561 69 61 73 92 156 358 246 104 77 39 47 239
2024/20251.233 241 501 470 21 0 0 0 0 0 0 0 0
Totale 10.403